The incidence of tuberculosis was found to be 5.8% (16/274) in 274 kidney g
raft recipients in our centre between 1986 and 1998, The kidney recipients
were evaluated retrospectively. A total of 51 recipients received isoniazid
prophylaxis for 6 months. The prevalence of tuberculosis was found similar
(6% vs. 8,8%, p = 0.15) between recipients with prophylaxis and no prophyl
axis, Eight patients were recipients of cadaveric donor kidneys and 8 were
recipients of living donor kidneys. Lungs were the most frequently affected
site, as in the normal population. M, tuberculosis grew in 7 patients. In
5 patients, M. tuberculosis was also detected on direct microscopy and poly
merase chain reaction. In 4 patients, diagnosis was made on clinical ground
s and later confirmed by positive response to therapy. In 8 patients, invas
ive procedures were performed for diagnosis. Five patients had miliary tube
rculosis at the time of diagnosis. In 3 patients dissemination occurred dur
ing follow-up. Nine patients responded to anti-tuberculous therapy while st
ill preserving their graft function, 1 patient rejected the graft while und
er treatment and returned to haemodialysis. Five patients (31%) died. Since
the risk of dissemination of tuberculosis is high in these patients, anti-
tuberculous therapy should be started whenever clinical findings suggestive
of tuberculosis are present, even in the absence of any microbiological an
d/or histological evidence.